Dreyer Scott
SEC CIK 1746251 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | EVP, Chief Commercial Off | 75.3K | — | $11.43M | 33 | 2021-07-12 | 2026-03-03 |
Most active insiders at COLL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dreyer Scott | EVP, Chief Commercial Off | — | $2.87M |
| 2 | Fallon John A. | Dir | — | $1.65M |
| 3 | Tupper Colleen | EVP, CFO | — | $1.22M |
| 4 | Dieter David | EVP, GC | — | $716.2K |
| 5 | BOHLIN GAREN G | Dir | — | $323.5K |
| 6 | Balice-Gordon Rita J. | Dir | — | $171.7K |
| 7 | Lurker Nancy | Dir | — | $161.9K |
| 8 | Freund John Gordon | Dir | — | $143.2K |
| 9 | Glancy Donovan Michael | Dir | — | — |
| 10 | Smith Thomas B | EVP, Chief Medical Off | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-05 | 2026-03-03 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $40.40 | -50.0K | 75.3K | -40% | -$2.02M |
| M | 2026-02-12 | 2026-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $46.75 | -31.6K | 143.4K | -18% | -$1.48M |
| M | 2026-02-12 | 2026-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +49.7K | 122.6K | +68% | $0 |
| DM | 2025-12-10 | 2025-12-08 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $48.17 | -17.6K | 103.6K | -15% | -$847.8K |
| D | 2025-12-10 | 2025-12-08 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $15.90 | +17.6K | 121.2K | +17% | +$279.8K |
| D | 2025-08-20 | 2025-08-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $21.34 | +16.4K | 120.0K | +16% | +$349.7K |
| D | 2025-08-20 | 2025-08-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $38.21 | -16.4K | 103.6K | -14% | -$626.2K |
| D | 2025-08-15 | 2025-08-13 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $21.34 | +4,861 | 108.5K | +5% | +$103.7K |
| D | 2025-08-15 | 2025-08-13 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $38.03 | -4,861 | 103.6K | -4% | -$184.9K |
| M | 2025-03-24 | 2025-03-20+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.03 | -20.8K | 122.5K | -15% | -$624.8K |
| 2025-03-18 | 2025-03-14 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -2,255 | 124.4K | -2% | -$67.7K | |
| A | 2025-03-18 | 2025-03-11 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -15.4K | 126.7K | -11% | -$461.6K |
| 2025-03-13 | 2025-03-06 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -15.4K | 126.7K | -11% | -$461.6K | |
| M | 2025-03-10 | 2025-03-06+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $30.00 | -5,643 | 142.1K | -4% | -$169.3K |
| M | 2025-02-12 | 2025-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $30.52 | -29.6K | 169.4K | -15% | -$904.1K |
| M | 2025-02-12 | 2025-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +71.4K | 177.3K | +67% | $0 |
| DM | 2024-05-28 | 2024-05-23+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale+OE | $33.90 | -108.0K | 138.9K | -44% | -$3.66M |
| DM | 2024-05-28 | 2024-05-23+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | M - OptEx | $24.03 | +75.0K | 190.1K | +65% | +$1.80M |
| M | 2024-02-28 | 2024-02-26 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $36.43 | -10.0K | 138.9K | -7% | -$364.3K |
| M | 2024-02-14 | 2024-02-12 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +67.3K | 146.3K | +85% | $0 |
| M | 2024-02-14 | 2024-02-12 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $33.70 | -29.7K | 159.1K | -16% | -$1.00M |
| 2024-01-18 | 2024-01-16 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $32.28 | -23.6K | 111.3K | -17% | -$760.5K | |
| 2023-03-03 | 2023-03-01 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $26.70 | -13.3K | 134.9K | -9% | -$355.8K | |
| M | 2023-02-14 | 2023-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $26.75 | -21.3K | 155.0K | -12% | -$570.5K |
| M | 2023-02-14 | 2023-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +66.7K | 169.5K | +65% | $0 |
| M | 2023-01-11 | 2023-01-09 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $27.39 | -17.8K | 110.2K | -14% | -$488.6K |
| 2022-07-13 | 2022-07-11 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $17.48 | -594 | 120.6K | -0.5% | -$10.4K | |
| 2022-02-28 | 2022-02-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $21.61 | -10.6K | 121.2K | -8% | -$228.2K | |
| M | 2022-02-14 | 2022-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | A - Grant | $0.00 | +66.2K | 142.4K | +87% | $0 |
| M | 2022-02-14 | 2022-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $17.63 | -10.7K | 131.8K | -7% | -$187.9K |
| 2022-01-12 | 2022-01-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $19.05 | -701 | 76.3K | -0.9% | -$13.4K | |
| 2021-12-17 | 2021-12-15 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | S - Sale | $18.33 | -5,693 | 77.0K | -7% | -$104.4K | |
| 2021-07-14 | 2021-07-12 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP, Chief Commercial Off | F - Tax | $23.17 | -595 | 82.7K | -0.7% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations